This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: National Taiwan University. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Mong-Hsun Tsai: Innovator in Esophageal Cancer Research
Introduction
Mong-Hsun Tsai is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer research, particularly in understanding the genetic factors that influence treatment responses in esophageal cancer patients. His work is vital for improving patient outcomes through personalized medicine.
Latest Patents
Mong-Hsun Tsai holds a patent titled "Biomarkers for predicting response of esophageal cancer patient to chemoradiotherapy." This invention relates to novel genetic markers associated with the response of a patient with esophageal cancer to chemoradiation therapy. The patent outlines methods and kits for predicting a patient's response by genotyping these markers. He has 1 patent to his name.
Career Highlights
Mong-Hsun Tsai is affiliated with National Taiwan University, where he conducts research and collaborates with other experts in the field. His work focuses on advancing the understanding of cancer treatment and improving therapeutic strategies for patients.
Collaborations
Mong-Hsun Tsai has worked alongside notable colleagues, including Pei-Wen Yang and Eric Chuang. Their collaborative efforts contribute to the ongoing research and development of innovative solutions in cancer treatment.
Conclusion
Mong-Hsun Tsai's contributions to cancer research, particularly through his patented work on biomarkers, highlight the importance of innovation in medical science. His efforts pave the way for more effective treatment options for esophageal cancer patients.